Fresenius Kabi
- Advanced Therapies Europe
- Bronze Sponsor
- Devices and hardware
- Consumables, disposables and perishables
- Stem Cell
- Immunotherapy
- Gene Therapy
- Cell Therapy
- Cell Based-IO
- Offering a product/service/solution to therapy developers and other parties
){kind=logo}
As part of Fresenius, Fresenius Kabi specializes in lifesaving medicines, medical technologies, and solutions for critically and chronically ill patients. With more than 41,000 employees and operations in over 100 countries, we help deliver care for 450 million patients each year.
In MedTech, we are the connective tissue between patients and donors, healthcare professionals, technology, and positive outcomes. Our portfolio spans blood collection, infusion therapy, cell and gene therapy manufacturing, and nutrition. One million of our infusion pumps are currently in use in hospitals worldwide, and 25% of global blood donations are collected in our bags. Our solutions are designed to streamline workflows, reduce waste, and support consistent, high-quality care.
We drive continuous improvement through innovation and by ensuring the quality standards and supply resilience healthcare systems depend on. By empowering people and enabling healthcare professionals to do their jobs better, we help support future-ready and efficient healthcare systems.
Lovo® Cell Processing System: https://www.chooselovo.com
Cue® Cell Processing System: https://www.choosecue.com
Address
Else-Kröner Str. 1Bad Homburg
61352
Germany
Contact Exhibitor
Stay ahead of the curve with curated content from across the advanced therapies industry. From breaking news and regulatory updates to expert interviews and event highlights.
-
)
Fresenius Kabi is advancing cell therapy manufacturing with flexible, automation-ready solutions. In this AT-TV interview from Advanced Therapies Week 2025, leaders from Fresenius Kabi discuss how the ...